Glatt Pharmaceutical Services

Binzen, Germany
Multiparticulate Systems Pellets Micropellets Granules Fluid Bed Coating Wurster Coating Spray Coating Modified Release Oral Solid Dose
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Glatt Pharmaceutical Services

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Binzen, Germany
Modalities
Multiparticulate Systems, Pellets, Micropellets, Granules, Fluid Bed Coating, Wurster Coating, Spray Coating, Modified Release, Oral Solid Dose
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Glatt Pharmaceutical Services

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesMultiparticulate Systems, Pellets, Micropellets, Granules, Fluid Bed Coating, Wurster Coating, Spray Coating, Modified Release, Oral Solid Dose
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (9 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (9 modalities)

Frequently Asked Questions About Glatt Pharmaceutical Services

What is Glatt Pharmaceutical Services's CDMO Signal Score?
Glatt Pharmaceutical Services has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Glatt Pharmaceutical Services for a manufacturing program?
Use the free AI matchmaker to compare Glatt Pharmaceutical Services against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Bend Bioscience
Bend, OR
Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Multiparticulates, Modified Release, Small Molecule API
Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines
Codis
St. Louis, MO (UK site: Haverhill, Suffolk, UK)
Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Finished Dose Manufacturing, Commercial-Scale Spray Drying
Cambrex Corporation
East Rutherford, NJ
Small Molecule API, HPAPI, Controlled Substances, Oral Solid Dose, Solid State Research, Particle Engineering, Drug Product (OSD), Controlled Release
Torrent Pharmaceuticals Limited
Ahmedabad, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Generic Drug Products, CDMO (via JB Pharma acquisition)